Cartalax
Research-Grade Peptide Bioregulator (Cartilage Tissue)
Tagline: Cartilage Gene Regulation Research
Product Description
Cartalax is a short synthetic peptide bioregulator derived from naturally occurring regulatory peptides associated with cartilage tissue. It belongs to the class of tissue-specific peptide bioregulators (cytomedins) that are studied for their ability to modulate gene expression, protein synthesis, and cellular homeostasis in a tissue-selective manner.
In laboratory research, Cartalax is used as a model peptide to study chondrocyte gene regulation, extracellular matrix metabolism, cartilage aging processes, and tissue-specific regulatory signaling. Like other short bioregulator peptides, Cartalax is investigated for epigenetic and nuclear-level interactions rather than receptor-based pharmacology.
For Laboratory and Scientific Research Use Only. Not for Human Consumption.
Why Researchers Choose Cartalax
-
Cartilage-specific peptide bioregulator model
-
Used in chondrocyte gene-expression studies
-
Supports cartilage aging & cellular homeostasis research
-
Short peptide structure (high nuclear compatibility)
-
Part of a well-documented peptide bioregulator class
-
Suitable for comparative connective tissue studies
Important Note
For laboratory and scientific research only. Not for human consumption, diagnostic, or therapeutic use.
